iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance

Tonack, Sarah; Jenkinson, C; F. Cox, Trevor; A. Elliott, Victoria; E. Jenkins, Rosalind; Kitteringham, N.R.; Greenhalf, William; Shaw, Victoria; Michalski, Christoph; Friess, Helmut; P. Neoptolemos, John; Costello, Eithne

doi:10.1038/bjc.2013.150

Public

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance

Published in British Journal of Cancer • Apr 11, 2013

Authors:

Sarah Tonack

C Jenkinson

Trevor F. Cox

Abstract

BACKGROUND: The aims of our study were to identify serum biomarkers that distinguish pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) patients from benign pancreatic disease patients and healthy subjects, and to assess the effects of jaundice on biomarker performance. METHODS: Isobaric tag...

Subject

Jaundice

Medicine

Pancreatic cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!